Clincosm LogoSign in Get a demo

myelodysplastic syndrome

Showing NaN - NaN of 47
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid

Withdrawn
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +11 more
  • Multi-antigen CMV-Modified Vaccinia Ankara Vaccine
  • +2 more
  • Duarte, California
  • +2 more
Nov 19, 2018

Aplastic Anemia, Leukemia, Myelodysplastic Syndrome Trial in United States (Busulfan, fludarabine, & cyclophosphamide with

Completed
Has Results
  • Aplastic Anemia
  • +2 more
  • Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.
  • CliniMACS device
  • Boston, Massachusetts
  • +5 more
Jun 14, 2018

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Multiple Myeloma Trial in Boston (CM-CS1 T-cell infusion)

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • CM-CS1 T-cell infusion
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
May 30, 2018

Lymphoma, Leukemia, Multiple Myeloma Trial in Boston (MEDI-507, Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant)

Terminated
  • Lymphoma
  • +3 more
  • MEDI-507
  • Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 14, 2018

Lymphoma, Leukemia, Multiple Myeloma Trial in Boston (Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant, T-cell depleted

Terminated
  • Lymphoma
  • +3 more
  • Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant
  • T-cell depleted peripheral blood stem cell transplant
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 14, 2018

Myelodysplastic Syndrome Trial in Worldwide (eltrombopag olamine, Placebo)

Completed
  • Myelodysplastic Syndrome
  • eltrombopag olamine
  • Placebo
  • Birmingham, Alabama
  • +64 more
Nov 8, 2017

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Boston (Busulfan, Clofarabine,

Completed
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jun 14, 2017

Leukemia, Lymphoma, Myelodysplastic Syndrome Trial in Boston (Bortezomib, Tacrolimus, Methotrexate)

Completed
Has Results
  • Leukemia
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
May 23, 2017

AML, ALL, CLL Trial in Boston (Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF)

Completed
  • AML
  • +8 more
  • Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jul 14, 2016

Lymphoma, Leukemia, Multiple Myeloma Trial in Boston (sequential cord blood transplantation)

Completed
  • Lymphoma
  • +3 more
  • sequential cord blood transplantation
  • Boston, Massachusetts
  • +1 more
May 9, 2016

Myelodysplastic Syndrome Trial in Worldwide (Siltuximab, Placebo, Best supportive care (BSC))

Terminated
Has Results
  • Myelodysplastic Syndrome
  • Tampa, Florida
  • +22 more
Sep 24, 2014

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in United States (MLN4924, Azacitidine)

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • Stanford, California
  • +5 more
Dec 3, 2013

Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • VCL-CB01
  • Phosphate-buffered Saline (PBS)
  • Tucson, Arizona
  • +21 more
Jul 31, 2013

Myelodysplastic Syndrome Trial in United States (Ezatiostat Hydrochloride, Lenalidomide (Revlimid®))

Completed
  • Myelodysplastic Syndrome
  • Ezatiostat Hydrochloride
  • Lenalidomide (Revlimid®)
  • Phoenix, Arizona
  • +8 more
Jun 4, 2013

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Boston (deferoxamine)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • Boston, Massachusetts
  • +1 more
Apr 5, 2013

Iron Overload in Stem Cell Transplantation

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • No Intervention
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Feb 26, 2013

Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Boston (Collection of Leukemia Cells)

Completed
  • Myelodysplastic Syndrome
  • Acute Myeloid Leukemia
  • Collection of Leukemia Cells
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 6, 2013

Myelodysplastic Syndrome Trial in United States (decitabine (5-aza-2'deoxycytidine))

Completed
  • Myelodysplastic Syndrome
  • decitabine (5-aza-2'deoxycytidine)
  • Berkeley, California
  • +23 more
Jan 22, 2013

Hematologic Malignancies, Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Boston (Sirolimus, Tacrolimus)

Completed
  • Hematologic Malignancies
  • +5 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 24, 2012

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Boston (All-trans retinoic acid, Bryostatin 1)

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • All-trans retinoic acid
  • Bryostatin 1
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 9, 2011

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (CT53518)

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Los Angeles, California
  • +4 more
Mar 23, 2009

Myelodysplastic Syndrome Trial in Boston (bortezomib)

Terminated
  • Myelodysplastic Syndrome
  • Boston, Massachusetts
  • +2 more
Mar 7, 2008